abnormal neuroanatomy (with CspR1), with Scer\GAL4elav-C155
partially lethal | temperature conditional (with CspR1), with Scer\GAL4elav-C155
NMJ bouton (with CspR1), with Scer\GAL4elav-C155
Presynaptic expression of CspΔJ.Scer\UAS under the control of Scer\GAL4elav-C155 results in approximately 98% viability at 25[o]C.
Motor neuron-specific expression of CspΔL.Scer\UAS (under the control of Scer\GAL4D42 significantly increases evoked EJP amplitudes at CspR1 mutant neuromuscular junctions from 52 to 98% of control EJPs. The increased EJP amplitudes are statistically indistinguishable from wild-type controls. Expression of CspΔL.Scer\UAS does not affect mEJP amplitude or frequency in CspR1 mutants.
Scer\GAL4Toll-6-D42/CspΔL.UAS fails to rescue CspR1
Scer\GAL4elav-C155/CspΔL.UAS fails to rescue CspR1
Motor neuron-specific expression of CspΔL.Scer\UAS (under the control of Scer\GAL4D42 significantly increases evoked EJP amplitudes at CspR1 mutant neuromuscular junctions from 52 to 98% of control EJPs. The increased EJP amplitudes are statistically indistinguishable from wild-type controls. Expression of CspΔL.Scer\UAS does not affect mEJP amplitude or frequency in CspR1 mutants.
Expression of CspΔL.Scer\UAS at CspR1 mutant neuromuscular junctions (under the control of Scer\GAL4D42) greatly reduces the abnormally increased frequency of asynchronous release shortly after the evoked EJP.
Expression of CspΔL.Scer\UAS (under the control of Scer\GAL4D42) restores the thermo-tolerance of evoked release at CspR1 mutant neuromuscular junctions. No difference is observed in spontaneous quantal release compared to controls. Neither mEJP frequency nor mEJP amplitude are significantly different between 22[o]C and 32[o]C in CspR1 mutants expressing CspΔL.Scer\UAS (under the control of Scer\GAL4D42).
At 30[o]C, motor neuron-specific expression of CspΔL.Scer\UAS (under the control of Scer\GAL4D42 partially reverses the abnormally high '[Ca[2+]'] resting levels of CspR1 mutant boutons to an intermediate level of 93.4nM. Statistically, '[Ca[2+]'] levels at 30[o]C are significantly different from those seen in CspR1 mutants and CspR1 mutants expressing CspΔJ.Scer\UAS. At 20[o]C, expression of CspΔL.Scer\UAS has no significant effect on the intraterminal '[Ca[2+]'].
Expression of CspΔL.Scer\UAS in CspR1 mutant neuromuscular junctions (under the control of Scer\GAL4D42) partially restores normal intraterminal
'[Ca[2+]'] levels at 30[o]C. Ca[2+] signals at rest, during and after stimulation, reaches intermediate levels, being significantly higher than those of wild-type controls at 30[o]C, but also clearly lower than those of CspR1 mutants.
Expression of CspΔL.Scer\UAS at CspR1 mutant neuromuscular junctions (under the control of Scer\GAL4D42), restores the thermo-tolerance of release: at 32[o]C, the average EJP amplitude is slight reduced by 16% but is not significantly different to wild-type controls. Neither mEJP frequency onor mEJP amplitude is significantly different between the groups at 22 or 32[o]C.
Expression of CspΔL.Scer\UAS at CspR1 mutant neuromuscular junctions (under the control of Scer\GAL4D42) significantly reduces the frequency of asynchronous release shortly after the evoked EJP.